The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1104
May 14, 2001
View Complete Issue         Table of Contents 2019 
Formoterol (Foradil Aerolizer) For Asthma
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Formoterol (Foradil Aerolizer) For Asthma
May 14, 2001 (Issue: 1104)
Formoterol fumarate inhalation powder Foradil Aerolizer, a long-acting beta2-adrenergic receptor agonist, has been approved by the FDA for maintenance treatment of asthma and prevention of exercise-induced bronchospasm. The drug has been available in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Formoterol (Foradil Aerolizer) For Asthma
Article code: 1104a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.